В Тюмени у 67-летнего мужчины случайно обнаружили рак легкого
В Тюмени у 67-летнего мужчины случайно обнаружили рак легкого МегаТюмень
277 материалов по теме, собраны автоматически из проверенных источников
В Тюмени у 67-летнего мужчины случайно обнаружили рак легкого МегаТюмень
From professor to patient: One man's journey on the frontier of lung cancer treatment NPR
Одно средство, два разных эффекта: пищевые добавки по-разному влияют на рак легких у женщин и мужчин Поиск - новости науки и техники
Astellas Doses First Patient in Phase 3 Trial of Setidegrasib for KRAS G12D-Mutated Lung Cancer BioPharma APAC
Radiation Oncology’s Biggest Meeting Returns to Boston With Landmark Trials in Breast, Liver and Lung Cancer Bioengineer.org
Ifinatamab Deruxtecan Biologics License Application for Certain Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer Voluntarily Withdrawn Business Wire
A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that a dietary form of a naturally occurring molecule called calcium alpha-ketoglutarate, or Ca-αKG, reduced lung tumor growth in female mice and activated genes associated with better outcomes in women with lung cancer. The…
Optimizing Perioperative Treatment in Resectable Non-Small Cell Lung Cancer Oncology News Central
Researchers at The University of Texas MD Anderson Cancer Center have developed an artificial intelligence (AI) model that can identify lung cancer patients at increased risk of developing a serious immunotherapy-related side effect before treatment begins, offering a possible path toward more personalized monitoring…
Astellas moves KRAS G12D degrader setidegrasib into Phase III lung cancer trial AllSci
Human breath could help identify cancerous lung nodules and reduce the need for invasive testing. New Griffith University research analyzed exhaled breath to help doctors distinguish between cancerous and noncancerous lung nodules, supporting earlier lung cancer diagnosis. Approximately 2.5 million new cases of lung…
UK Approves Lurbinectedin Plus Atezolizumab as First-Line Maintenance Therapy for Small Cell Lung Cancer Oncodaily
Precision Radiation Therapy Alone Doubles Historical Survival Rates for Inoperable Lung Cancer, Landmark Lancet Trial Finds PR Newswire
Astellas Starts Phase 3 Trial of Setidegrasib vs Docetaxel in KRAS G12D Lung Cancer The Clinical Trial Vanguard
Osimertinib Maintains 8-Year Overall Survival in EGFR+ Lung Cancer Oncology News Central